Studies Conducted at Massachusetts General Hospital and Harvard Medical School on Glioblastomas Recently Published (Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models).

Předmět:	IMMUNE checkpoint proteins LOSARTAN GLIOBLASTOMA multiforme MEDICAL schools LABORATORY mice
Zdroj:	Drug Week; 2/24/2023, p991-991, 1p
Abstrakt:	Angiotensin II Inhibitors, Angiotensin II Receptor Antagonist, Antiarrhythmic Agents, Antihypertensives, Biphenyl Compounds, Cancer, Cardiovascular Agents, Drugs and Therapies, Edema, Glioblastomas, Health and Medicine, Hydrocarbons, Losartan, Losartan Therapy, Oncology, Pharmaceuticals Keywords: Angiotensin II Inhibitors; Angiotensin II Receptor Antagonist; Antiarrhythmic Agents; Antihypertensives; Biphenyl Compounds; Cancer; Cardiovascular Agents; Drugs and Therapies; Edema; Glioblastomas; Health and Medicine; Hydrocarbons; Losartan; Losartan Therapy; Oncology; Pharmaceuticals EN Angiotensin II Inhibitors Angiotensin II Receptor Antagonist Antiarrhythmic Agents Antihypertensives Biphenyl Compounds Cancer Cardiovascular Agents Drugs and Therapies Edema Glioblastomas Health and Medicine Hydrocarbons Losartan Losartan Therapy Oncology Pharmaceuticals 991 991 1 03/24/23 20230224 NES 230224 2023 FEB 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on glioblastomas. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu